Create a narrative

MacroGenics Community

NasdaqGS:MGNX Community

1 Narratives written by author
0 Comments on narratives written by author
5 Fair Values set on narratives written by author

Create a narrative

AN

AnalystConsensusTarget

Consensus Narrative from 5 Analysts

LORIKEET And LINNET Trials Will Spur Advances Amid Liquidity Risks

Key Takeaways Future revenue growth potential hinges on successful trial outcomes and product approvals in ongoing and upcoming clinical studies. A robust pipeline and financial sustainability support continued R&D efforts, reinforcing prospects for growth if new treatments prove effective.

US$5.80

FV

70.1% undervalued

-28.74%

Revenue growth p.a.

0

0

5

7 days ago